Database study for kids and young adults with AML
Part of Blood & lymphatic, Cancer clinical trials.
This study collects health information from young people with a type of blood cancer called acute myeloid leukemia (AML). The goal is to learn more about the disease and improve future treatments. If you are under 25 and being treated for AML at a hospital in France, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Under 25 years old
- Diagnosed with acute myeloid leukemia (AML)
- Being treated at a hospital in France that is part of this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This non-interventional study follows adults with acute myeloid leukemia (AML) to better understand the disease and how patients do in real-world care. It may help researchers compare outcomes across different types of AML, but you would not receive a study treatment just for joining.
This study enrolls adults with acute myeloid leukemia (AML) to build a detailed registry and store biological samples. It helps researchers understand AML better and may support future studies.
This trial looks at how childhood, teen, and young adult acute myeloid leukemia (AML) changes at the genetic level and how cells respond to multiple drugs. It may help doctors understand which treatments work best and how leukemia interacts with supportive cells in the bone marrow.
This study is for adults with acute myeloid leukemia (AML) whose cancer has returned or is not responding to treatment. Researchers will analyze your leukemia cells to learn more about the disease and possibly find better treatments.
This study looks at how acute myeloid leukemia behaves over time in adults and may help doctors better predict outcomes. You might be eligible if you have AML and agree to take part in research.
This study tests a treatment plan for children under 18 with a new diagnosis of acute myeloid leukemia (AML). It aims to provide effective therapy based on standard guidelines, and may include children with certain blood or bone marrow findings even if tests are limited.
Hear when a new Acute Myeloid Leukemia (AML) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.